PROTAGENIC THERAPEUTICS, INC.
PROTAGENIC THERAPEUTICS, INC. is a Private limited company (Ltd.) registered in United States under 3546264, and its current status with New York Department of State — Division of Corporations is active. The company was incorporated on 23 July 2007 and lists its registered address as NEW YORK, United States. 5 shareholders are on record for PROTAGENIC THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New York Department of State — Division of Corporations and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for PROTAGENIC THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Fidelity Concord Street Trust-Fidelity Extended Market Index Fund, holding 1.5% — the largest recorded stake — followed by Geode Capital Management, LLC at 1.4%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 12 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 1.5% | New York Department of State — Division of Corporations | |
| Geode Capital Management, LLC | 1.4% | New York Department of State — Division of Corporations | |
| Vanguard Group Inc | 1.1% | New York Department of State — Division of Corporations | |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1% | New York Department of State — Division of Corporations | |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.7% | New York Department of State — Division of Corporations |
Officers
5
The Co-founder & Executive Chairman Of The Board of PROTAGENIC THERAPEUTICS, INC. currently on record is Garo H. Armen Ph.d.; five officers are currently on record for PROTAGENIC THERAPEUTICS, INC., filed with New York Department of State — Division of Corporations.
The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at PROTAGENIC THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns PROTAGENIC THERAPEUTICS, INC.?
Five shareholders are currently on record for PROTAGENIC THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Fidelity Concord Street Trust-Fidelity Extended Market Index Fund, holding 1.5% — the largest recorded stake — followed by Geode Capital Management, LLC at 1.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is PROTAGENIC THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for PROTAGENIC THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does PROTAGENIC THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for PROTAGENIC THERAPEUTICS, INC.. The register reports 12 in total; only the top 5 by holding are shown here.
What is PROTAGENIC THERAPEUTICS, INC.'s company registration number?
PROTAGENIC THERAPEUTICS, INC.'s registration number is 3546264, filed with New York Department of State — Division of Corporations in United States. Its current status on the register is active.
Is PROTAGENIC THERAPEUTICS, INC. still an active company?
PROTAGENIC THERAPEUTICS, INC.'s status on New York Department of State — Division of Corporations is listed as active.
When was PROTAGENIC THERAPEUTICS, INC. incorporated?
PROTAGENIC THERAPEUTICS, INC. was incorporated on 23 July 2007, according to New York Department of State — Division of Corporations.
What is PROTAGENIC THERAPEUTICS, INC.'s registered address?
The registered address on file for PROTAGENIC THERAPEUTICS, INC. is NEW YORK, United States.
What legal structure is PROTAGENIC THERAPEUTICS, INC. registered as?
PROTAGENIC THERAPEUTICS, INC. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of PROTAGENIC THERAPEUTICS, INC.?
The Co-founder & Executive Chairman Of The Board of PROTAGENIC THERAPEUTICS, INC. currently on record is Garo H. Armen Ph.d.; five officers are currently on record for PROTAGENIC THERAPEUTICS, INC., filed with New York Department of State — Division of Corporations. Management authority at PROTAGENIC THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to PROTAGENIC THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from New York Department of State — Division of Corporations. Zavia's monitoring API can track changes to PROTAGENIC THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access PROTAGENIC THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like PROTAGENIC THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New York Department of State — Division of Corporations and was last synced on 21 October 2026.